PEDIARIX has never had a vaccine shortage in its 17-year history, while other manufacturers had primary series DTaP or pediatric HepB shortages that lasted a year or more1,2
GSK—the single manufacturer of all antigens in PEDIARIX—has a consistent DTaP supply record over the last 17 years, giving you the confidence of supply reliability.2,3
DTaP=diphtheria, tetanus, and acellular pertussis; HepB=hepatitis B.
*Data as of March 2019. Shortages of vaccines were identified by the Center for Biologics Evaluation and Research (CBER) within the Food and Drug Administration. CBER works closely with the manufacturer to voluntarily obtain accurate information.
References: 1. CBER-regulated products: resolved shortages. US Food & Drug Administration website. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/Shortages/default.htm. Updated March 20, 2019. Accessed September 4, 2019. 2. Prescribing Information for PEDIARIX. 3. Data on File, GSK. 4. Plotkin S, Robinson JM, Cunningham G, et al. The complexity and cost of vaccine manufacturing—an overview. Vaccine. 2017;35(33):4064-4071.